Short stature-delayed bone age due to thyroid hormone metabolism deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:171706OMIM:619855E03.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Short stature-delayed bone age due to thyroid hormone metabolism deficiency is a rare endocrine disorder caused by defects in the intracellular metabolism of thyroid hormones, leading to a form of congenital hypothyroidism. This condition is primarily associated with mutations in the SBP2 (SECISBP2) gene, which encodes a selenocysteine insertion sequence-binding protein essential for the synthesis of selenoproteins, including the deiodinase enzymes responsible for converting the prohormone thyroxine (T4) into the biologically active triiodothyronine (T3). Impaired deiodinase activity results in abnormal thyroid hormone levels, typically characterized by elevated T4 and reverse T3 (rT3) with low T3 levels, and mildly elevated TSH. The condition primarily affects the skeletal and endocrine systems. Key clinical features include proportionate short stature, significantly delayed bone age, and growth retardation during childhood. Patients may also exhibit features of mild hypothyroidism at the tissue level despite apparently normal or elevated circulating T4 levels, which can make initial diagnosis challenging. Additional features may include transient hearing impairment, mild intellectual delay, and increased sensitivity to oxidative stress due to broader selenoprotein deficiency. The thyroid hormone profile is distinctive and helps guide diagnosis. Treatment options are limited and primarily supportive. Selenium supplementation and careful thyroid hormone replacement with T3 (liothyronine) have been explored in some patients, with variable clinical benefit. Growth hormone therapy is generally not indicated unless concurrent growth hormone deficiency is documented. Long-term monitoring of growth, bone maturation, thyroid function, and neurodevelopmental outcomes is recommended. The condition is extremely rare, with only a small number of families reported worldwide.

Clinical phenotype terms— hover any for plain English:

Elevated circulating thyroid-stimulating hormone concentrationHP:0002925Increased circulating T4 concentrationHP:0031506Decreased circulating free T3HP:0032210Fasting hypoglycemiaHP:0003162Fatty replacement of skeletal muscleHP:0012548Abnormal circulating selenium concentrationHP:0031903Abnormal circulating insulin concentrationHP:0040214
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Short stature-delayed bone age due to thyroid hormone metabolism deficiency.

View clinical trials →

No actively recruiting trials found for Short stature-delayed bone age due to thyroid hormone metabolism deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Short stature-delayed bone age due to thyroid hormone metabolism deficiency community →

No specialists are currently listed for Short stature-delayed bone age due to thyroid hormone metabolism deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Short stature-delayed bone age due to thyroid hormone metabolism deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Short stature-delayed bone age due to thyroid hormone metabolism deficiencyForum →

No community posts yet. Be the first to share your experience with Short stature-delayed bone age due to thyroid hormone metabolism deficiency.

Start the conversation →

Latest news about Short stature-delayed bone age due to thyroid hormone metabolism deficiency

No recent news articles for Short stature-delayed bone age due to thyroid hormone metabolism deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Short stature-delayed bone age due to thyroid hormone metabolism deficiency

What is Short stature-delayed bone age due to thyroid hormone metabolism deficiency?

Short stature-delayed bone age due to thyroid hormone metabolism deficiency is a rare endocrine disorder caused by defects in the intracellular metabolism of thyroid hormones, leading to a form of congenital hypothyroidism. This condition is primarily associated with mutations in the SBP2 (SECISBP2) gene, which encodes a selenocysteine insertion sequence-binding protein essential for the synthesis of selenoproteins, including the deiodinase enzymes responsible for converting the prohormone thyroxine (T4) into the biologically active triiodothyronine (T3). Impaired deiodinase activity results i

How is Short stature-delayed bone age due to thyroid hormone metabolism deficiency inherited?

Short stature-delayed bone age due to thyroid hormone metabolism deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Short stature-delayed bone age due to thyroid hormone metabolism deficiency typically begin?

Typical onset of Short stature-delayed bone age due to thyroid hormone metabolism deficiency is childhood. Age of onset can vary across affected individuals.